UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

6-Mercaptopurine in ulcerative colitis: the potential of upfront dosing with allopurinol

Journal of Crohn's and colitis, 2024-03, Vol.18 (3), p.492-492

2024

Volltextzugriff (PDF)

Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease—More thought is needed

Alimentary pharmacology & therapeutics, 2023-10, Vol.58 (8), p.838-839

2023

Volltextzugriff (PDF)

Poor Bowel Preparation in Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.440-442

2020

Volltextzugriff (PDF)

Letter: Elderly onset inflammatory bowel disease—Treat to target approach is still warranted

Alimentary pharmacology & therapeutics, 2023-09, Vol.58 (5), p.556-557

2023

Volltextzugriff (PDF)

An Unusual Cause of Duodenal Ulceration

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.e3-e5

2020

Volltextzugriff (PDF)

Complex Fistulizing Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2020-03, Vol.158 (4), p.827-828

2020

Volltextzugriff (PDF)

A difficult pill to swallow: drug-induced oesophagitis

The Lancet (British edition), 2019-11, Vol.394 (10210), p.1764-1764

2019

Volltextzugriff (PDF)

Medical versus Surgical Treatment for Refractory Heartburn

The New England journal of medicine, 2020-01, Vol.382 (3), p.297

2020

Volltextzugriff (PDF)

Investigating Liver Masses in Young Adults

The American journal of medicine, 2021-05, Vol.134 (5), p.596-598

2021

Volltextzugriff (PDF)

Megacolon Complicating Ulcerative Colitis and Clostridiodes Infection

The American journal of the medical sciences, 2020-10, Vol.360 (4), p.e1-e2

2020

Volltextzugriff (PDF)

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply

Alimentary pharmacology & therapeutics, 2024-04, Vol.59 (8), p.1011-1011

2024

Volltextzugriff (PDF)

Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply

Alimentary pharmacology & therapeutics, 2024-03, Vol.59 (6), p.794-794

2024

Volltextzugriff (PDF)

Deep learning vs conventional learning algorithms for clinical prediction in Crohn's disease: A proof-of-concept study

World journal of gastroenterology : WJG, 2021-10, Vol.27 (38), p.6476-6488

2021

Volltextzugriff (PDF)

Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?

World journal of gastroenterology : WJG, 2017-09, Vol.23 (35), p.6385-6402

2017

Volltextzugriff (PDF)

Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment?

Inflammatory bowel diseases, 2024-03

2024

Volltextzugriff (PDF)

Inflammatory Bowel Disease Helpline Reduces Subsequent Inpatient Admission Rates

Journal of Crohn's and colitis, 2020-02, Vol.14 (2), p.281-281

2020

Volltextzugriff (PDF)

Orbital Inflammation in an Adult With Crohn Disease

JAMA ophthalmology, 2022-04, Vol.140 (4), p.426

2022

Volltextzugriff (PDF)

Editorial: delving into the natural history of Crohn’s disease and the impact of medical therapy

Alimentary pharmacology & therapeutics, 2022-01, Vol.55 (1), p.108-109

2022

Volltextzugriff (PDF)

Predictive Scores in Acute Severe Ulcerative Colitis: Which, What, and When are the Decision Points We Should Target?

Clinical gastroenterology and hepatology, 2022-02, Vol.20 (2), p.e344-e345

2022

Volltextzugriff (PDF)

Liver Failure Complicating a Febrile Illness in a Middle-Aged Man

Gastroenterology (New York, N.Y. 1943), 2016-06, Vol.150 (7), p.1542-1544

2016

Volltextzugriff (PDF)

The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn’s Disease in the Biosimilar Era

Inflammatory bowel diseases, 2020-02, Vol.26 (3), p.369-379

2020

Volltextzugriff (PDF)

Response to: Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlate With Rate of Infection

Clinical gastroenterology and hepatology, 2021-05, Vol.19 (5), p.1077-1077

2021

Volltextzugriff (PDF)

Approach to medical therapy in perianal Crohn's disease

World journal of gastroenterology : WJG, 2021-07, Vol.27 (25), p.3693-3704

2021

Volltextzugriff (PDF)

Treatment Targets Should Influence Choice of Infliximab Dose Intensification Strategy in Inflammatory Bowel Disease: A Pharmacokinetic Simulation Study

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2024-09, Vol.38 (5), p.691-702

2024

Volltextzugriff (PDF)

Letter: rationalising aminosalicylates in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2020-11, Vol.52 (10), p.1619-1620

2020

Volltextzugriff (PDF)

26 – 50 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(100)

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(75)
Gastroenterology & Hepatology
(51)
Humans
(41)
Inflammatory Bowel Disease
(19)
Pharmacology & Pharmacy
(17)
Female
(16)
Male
(16)
General & Internal Medicine
(12)
Middle Aged
(12)
Inflammatory Bowel Diseases
(11)
Inflammatory Bowel Diseases - Drug Therapy
(11)
Medicine, General & Internal
(11)
Crohn's Disease
(10)
Crohns Disease
(10)
Adult
(9)
Crohn Disease - Drug Therapy
(9)
Patients
(9)
Treatment Outcome
(9)
Ulcerative Colitis
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

6-Mercaptopurine in ulcerative colitis: the potential of upfront dosing with allopurinol

Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease—More thought is needed

Poor Bowel Preparation in Crohn’s Disease

Letter: Elderly onset inflammatory bowel disease—Treat to target approach is still warranted

An Unusual Cause of Duodenal Ulceration

Complex Fistulizing Crohn’s Disease

A difficult pill to swallow: drug-induced oesophagitis

Medical versus Surgical Treatment for Refractory Heartburn

Investigating Liver Masses in Young Adults

Megacolon Complicating Ulcerative Colitis and Clostridiodes Infection

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply

Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply

Deep learning vs conventional learning algorithms for clinical prediction in Crohn's disease: A proof-of-concept study

Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?

Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment?

Inflammatory Bowel Disease Helpline Reduces Subsequent Inpatient Admission Rates

Orbital Inflammation in an Adult With Crohn Disease

Editorial: delving into the natural history of Crohn’s disease and the impact of medical therapy

Predictive Scores in Acute Severe Ulcerative Colitis: Which, What, and When are the Decision Points We Should Target?

Liver Failure Complicating a Febrile Illness in a Middle-Aged Man

The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn’s Disease in the Biosimilar Era

Response to: Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlate With Rate of Infection

Approach to medical therapy in perianal Crohn's disease

Treatment Targets Should Influence Choice of Infliximab Dose Intensification Strategy in Inflammatory Bowel Disease: A Pharmacokinetic Simulation Study

Letter: rationalising aminosalicylates in inflammatory bowel disease

Suchergebnisse filtern